Labcorp offers new FDA-approved prostate cancer diagnostic test
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer
August 4, 2026 7:00 AM EDTFirst FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib)
BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services,... More
